RT @IlindelatorreMD: Se examinaron muestras de pulmón y piel de tres personas infectadas con COVID-19 y se descubrió que los capilares esta…
Se examinaron muestras de pulmón y piel de tres personas infectadas con COVID-19 y se descubrió que los capilares estaban obstruidos con micro trombos. https://t.co/mSbywVAn9p
RT @hahn_rt: Case: venous thromboembolism in #COVID19 with reports of PE https://t.co/q7FzQZG53n, thrombotic disease https://t.co/ovc1sRD0E…
RT @hahn_rt: Case: venous thromboembolism in #COVID19 with reports of PE https://t.co/q7FzQZG53n, thrombotic disease https://t.co/ovc1sRD0E…
Case: venous thromboembolism in #COVID19 with reports of PE https://t.co/s1oYh5TYXi, thrombotic disease https://t.co/daCp70UsZm…, and GREAT new @JACCJournals review led by @CU_Cardiology
RT @hahn_rt: Case: venous thromboembolism in #COVID19 with reports of PE https://t.co/q7FzQZG53n, thrombotic disease https://t.co/ovc1sRD0E…
RT @hahn_rt: Case: venous thromboembolism in #COVID19 with reports of PE https://t.co/q7FzQZG53n, thrombotic disease https://t.co/ovc1sRD0E…
RT @hahn_rt: Case: venous thromboembolism in #COVID19 with reports of PE https://t.co/q7FzQZG53n, thrombotic disease https://t.co/ovc1sRD0E…
RT @hahn_rt: Case: venous thromboembolism in #COVID19 with reports of PE https://t.co/q7FzQZG53n, thrombotic disease https://t.co/ovc1sRD0E…
RT @hahn_rt: Case: venous thromboembolism in #COVID19 with reports of PE https://t.co/q7FzQZG53n, thrombotic disease https://t.co/ovc1sRD0E…
RT @hahn_rt: Case: venous thromboembolism in #COVID19 with reports of PE https://t.co/q7FzQZG53n, thrombotic disease https://t.co/ovc1sRD0E…
RT @hahn_rt: Case: venous thromboembolism in #COVID19 with reports of PE https://t.co/q7FzQZG53n, thrombotic disease https://t.co/ovc1sRD0E…
RT @hahn_rt: Case: venous thromboembolism in #COVID19 with reports of PE https://t.co/q7FzQZG53n, thrombotic disease https://t.co/ovc1sRD0E…
RT @hahn_rt: Case: venous thromboembolism in #COVID19 with reports of PE https://t.co/q7FzQZG53n, thrombotic disease https://t.co/ovc1sRD0E…
RT @hahn_rt: Case: venous thromboembolism in #COVID19 with reports of PE https://t.co/q7FzQZG53n, thrombotic disease https://t.co/ovc1sRD0E…
RT @hahn_rt: Case: venous thromboembolism in #COVID19 with reports of PE https://t.co/q7FzQZG53n, thrombotic disease https://t.co/ovc1sRD0E…
RT @hahn_rt: Case: venous thromboembolism in #COVID19 with reports of PE https://t.co/q7FzQZG53n, thrombotic disease https://t.co/ovc1sRD0E…
RT @hahn_rt: Case: venous thromboembolism in #COVID19 with reports of PE https://t.co/q7FzQZG53n, thrombotic disease https://t.co/ovc1sRD0E…
RT @hahn_rt: Case: venous thromboembolism in #COVID19 with reports of PE https://t.co/q7FzQZG53n, thrombotic disease https://t.co/ovc1sRD0E…
RT @hahn_rt: Case: venous thromboembolism in #COVID19 with reports of PE https://t.co/q7FzQZG53n, thrombotic disease https://t.co/ovc1sRD0E…
RT @hahn_rt: Case: venous thromboembolism in #COVID19 with reports of PE https://t.co/q7FzQZG53n, thrombotic disease https://t.co/ovc1sRD0E…
RT @hahn_rt: Case: venous thromboembolism in #COVID19 with reports of PE https://t.co/q7FzQZG53n, thrombotic disease https://t.co/ovc1sRD0E…
RT @hahn_rt: Case: venous thromboembolism in #COVID19 with reports of PE https://t.co/q7FzQZG53n, thrombotic disease https://t.co/ovc1sRD0E…
RT @hahn_rt: Case: venous thromboembolism in #COVID19 with reports of PE https://t.co/q7FzQZG53n, thrombotic disease https://t.co/ovc1sRD0E…
RT @hahn_rt: Case: venous thromboembolism in #COVID19 with reports of PE https://t.co/q7FzQZG53n, thrombotic disease https://t.co/ovc1sRD0E…
RT @hahn_rt: Case: venous thromboembolism in #COVID19 with reports of PE https://t.co/q7FzQZG53n, thrombotic disease https://t.co/ovc1sRD0E…
Case: venous thromboembolism in #COVID19 with reports of PE https://t.co/q7FzQZG53n, thrombotic disease https://t.co/ovc1sRD0Et, and GREAT new @JACCJournals review led by @CU_Cardiology https://t.co/VzOyQCnCIK @ACCinTouch @CircAHA @ajaykirtane @ASE360 #ech
Incidence of thrombotic complications in critically ill ICU patients with COVID-19 https://t.co/pmmtX0BLtY
RT @thelonevirologi: Incidence of thrombotic complications in critically ill ICU patients with COVID-19 https://t.co/JePAe5G9zU
#COVID19 puede generar trombosis arterial/venosa. Un análisis de 184 pacientes reporta el 31% (punto compuesto EP, TVP, IAM, EVC). https://t.co/GMBdfzHldt Si tienes síntomas moderados de #COVID19 permanece en estricta vigilancia. @ANCAM_MEXICO @Iniciativ
RT @Veraptus: Incidence of thrombotic complications in critically ill ICU patients with COVID-19 https://t.co/7yD9rvLEcy #Changsha #Coronav…
RT @xto_p: @_atanas_ Refs needed: Large-Vessel Stroke as a Presenting Feature of Covid-19 in the Young https://t.co/ljUgzV37CZ Incidence o…
@JUMPUSER05 日本ではないですが、こんな論文あります。 https://t.co/1X23DqsSgm
RT @PulmCrit: *despite* DVT prophylaxis in severe COVID, 27% developed DVT/PE and 4% developed arterial thrombosis (#'s likely *low* 2/2 la…
RT @rbganatra: 1/ What is the risk of macrovascular thrombosis among critically ill patients with #SARSCoV2 #COVID19? Let’s take a look at…
RT @rbganatra: 1/ What is the risk of macrovascular thrombosis among critically ill patients with #SARSCoV2 #COVID19? Let’s take a look at…
Incidence of thrombotic complications in critically ill ICU patients with COVID-19 - ScienceDirect https://t.co/Z6DRzSN5S6
RT @iamahawkins: Great thread on the considerations for censoring data and impact on outcomes.
Incidence of thrombotic complications in critically ill ICU patients with COVID-19 - ScienceDirect https://t.co/HBdgzBLUK2
RT @rbganatra: 1/ What is the risk of macrovascular thrombosis among critically ill patients with #SARSCoV2 #COVID19? Let’s take a look at…
@OlifaNT @Br12019 @hannieschafthet Kawasaki-achtige symptomen; aangetastte bloedvaten. Aan de andere kant van het leeftijdsspectrum wordt er in NL en Frankrijk nu een verband onderzocht tussen SARS-COV-2 besmetting en trombose verschijnselen. https://t.co/
https://t.co/bMsBwcDr9G After #remDESIvir, Will #Argatroban Have To Take Lead Now In Management Of #COVID19 After @NEJM https://t.co/h5j895BkZU OR https://t.co/MbhUyNb8Uw OR Other Journals' https://t.co/1wHsaCb36A? @WHO @CDCgov @AmerMedicalAssn @ASALifelin
https://t.co/Y6x3S17qii After #remDESIvir, Will #Argatroban Have To Take Lead Now In Management Of #COVID19 After @NEJM https://t.co/h5j895BkZU OR https://t.co/MbhUyNb8Uw OR Other Journals' https://t.co/1wHsaCb36A? @WHO @CDCgov @AmerMedicalAssn @ASALifelin
https://t.co/H8g2Dweizs After #remDESIvir, Will #Argatroban Have To Take Lead Now In Management Of #COVID19 After @NEJM https://t.co/h5j895BkZU OR https://t.co/MbhUyNb8Uw OR Other Journals' https://t.co/1wHsaCb36A? @WHO @CDCgov @AmerMedicalAssn @ASALifelin
https://t.co/bas5BBOll6 After #remDESIvir, Will #Argatroban Have To Take Lead Now In Management Of #COVID19 After @NEJM https://t.co/uiH7PCxtRx OR https://t.co/4LqjpxdhW6 OR Other Journals' https://t.co/1OTjPY29YX? @WHO @CDCgov @AmerMedicalAssn @ASALifelin
Incidencia de complicaciones trombóticas en pacientes críticos en UCI con COVID-19 https://t.co/Vj62pO1q6U
RT @rbganatra: 1/ What is the risk of macrovascular thrombosis among critically ill patients with #SARSCoV2 #COVID19? Let’s take a look at…
RT @rbganatra: 1/ What is the risk of macrovascular thrombosis among critically ill patients with #SARSCoV2 #COVID19? Let’s take a look at…
RT @edgarvlermamd: Incidence of thrombotic complications in critically ill ICU patients with #COVID19 ca. 2020 👉🏼 https://t.co/3qZIKbdzTO h…
Great thread about this study. I wondered the same thing as @rbganatra in # 15: how come 31/184 equals 31% ???
Another excellent walk-thru by @rbganatra: “Incidence of thrombotic complications in critically ill ICU patients with COVID-19”.
RT @jsnellenburg: In the Dutch news today: ‘Half of corona patients on IC have clots in the lungs or brain’ #thrombosis in #COVID19 patien…
RT @edgarvlermamd: Incidence of thrombotic complications in critically ill ICU patients with #COVID19 ca. 2020 👉🏼 https://t.co/3qZIKbdzTO h…
RT @edgarvlermamd: Incidence of thrombotic complications in critically ill ICU patients with #COVID19 ca. 2020 👉🏼 https://t.co/3qZIKbdzTO h…
RT @jsnellenburg: In the Dutch news today: ‘Half of corona patients on IC have clots in the lungs or brain’ #thrombosis in #COVID19 patien…
RT @rbganatra: 1/ What is the risk of macrovascular thrombosis among critically ill patients with #SARSCoV2 #COVID19? Let’s take a look at…
RT @rbganatra: 1/ What is the risk of macrovascular thrombosis among critically ill patients with #SARSCoV2 #COVID19? Let’s take a look at…
RT @rbganatra: 1/ What is the risk of macrovascular thrombosis among critically ill patients with #SARSCoV2 #COVID19? Let’s take a look at…
RT @rbganatra: 1/ What is the risk of macrovascular thrombosis among critically ill patients with #SARSCoV2 #COVID19? Let’s take a look at…
RT @rbganatra: 1/ What is the risk of macrovascular thrombosis among critically ill patients with #SARSCoV2 #COVID19? Let’s take a look at…
RT @rbganatra: 1/ What is the risk of macrovascular thrombosis among critically ill patients with #SARSCoV2 #COVID19? Let’s take a look at…
RT @jsnellenburg: In the Dutch news today: ‘Half of corona patients on IC have clots in the lungs or brain’ #thrombosis in #COVID19 patien…
In the Dutch news today: ‘Half of corona patients on IC have clots in the lungs or brain’ #thrombosis in #COVID19 patients Relevant paper (graphic from paper): https://t.co/UBRVrcQagw https://t.co/IJHBzQ0v4j
RT @rbganatra: 1/ What is the risk of macrovascular thrombosis among critically ill patients with #SARSCoV2 #COVID19? Let’s take a look at…
RT @rbganatra: 1/ What is the risk of macrovascular thrombosis among critically ill patients with #SARSCoV2 #COVID19? Let’s take a look at…
Esto es: 1) Una clase magistral de cómo interpretar un artículo científico (muy por encima de mis posibilidades, por cierto) 2) Un recordatorio sobre la malísima calidad de la evidencia que las mejores revistas médicas están publicando sobre el #COVID__19
@BeulaEnu @Alexandre_Antwi @norriager @Jay_surg @MeatIsMeaty @BempahRose
MedTweetorial: #Tweetorial Author: @rbganatra Type: #Publication Specialty: #Hematology #Heme #HemeOnc #InfectiousDisease #ID Topics: #COVID19 #SARSCoV2 #Thrombosis #MacroVascularThrombosis
RT @rbganatra: 1/ What is the risk of macrovascular thrombosis among critically ill patients with #SARSCoV2 #COVID19? Let’s take a look at…
Once again, @rbganatra with an outstanding #MedThread breaking down a key paper. This is a very provocative topic, sure to be much more on it in the coming weeks/months
RT @rbganatra: 1/ What is the risk of macrovascular thrombosis among critically ill patients with #SARSCoV2 #COVID19? Let’s take a look at…
RT @rbganatra: 1/ What is the risk of macrovascular thrombosis among critically ill patients with #SARSCoV2 #COVID19? Let’s take a look at…
RT @rbganatra: 1/ What is the risk of macrovascular thrombosis among critically ill patients with #SARSCoV2 #COVID19? Let’s take a look at…
RT @RaphaelWimmer: @BogochIsaac @kakape How rare? "The 31% incidence of thrombotic complications in ICU patients with COVID-19 infections…
RT @RaphaelWimmer: @BogochIsaac @kakape How rare? "The 31% incidence of thrombotic complications in ICU patients with COVID-19 infections…
RT @RaphaelWimmer: @BogochIsaac @kakape How rare? "The 31% incidence of thrombotic complications in ICU patients with COVID-19 infections…
RT @RaphaelWimmer: @BogochIsaac @kakape How rare? "The 31% incidence of thrombotic complications in ICU patients with COVID-19 infections…
RT @rbganatra: 1/ What is the risk of macrovascular thrombosis among critically ill patients with #SARSCoV2 #COVID19? Let’s take a look at…
RT @rbganatra: 1/ What is the risk of macrovascular thrombosis among critically ill patients with #SARSCoV2 #COVID19? Let’s take a look at…
RT @rbganatra: 1/ What is the risk of macrovascular thrombosis among critically ill patients with #SARSCoV2 #COVID19? Let’s take a look at…
RT @rbganatra: 1/ What is the risk of macrovascular thrombosis among critically ill patients with #SARSCoV2 #COVID19? Let’s take a look at…
El aumento d incidencia d casos d trombosis en #COVID19 es básicamente por TEP y algunos TVP, no por IAM. https://t.co/gLH5BSOzTG
RT @rbganatra: 1/ What is the risk of macrovascular thrombosis among critically ill patients with #SARSCoV2 #COVID19? Let’s take a look at…
RT @rbganatra: 1/ What is the risk of macrovascular thrombosis among critically ill patients with #SARSCoV2 #COVID19? Let’s take a look at…
RT @SharkawyMD: More sobering news on the unusual thrombogenic diathesis triggered by this virus. And troubling that any form of anticoagu…
More sobering news on the unusual thrombogenic diathesis triggered by this virus. And troubling that any form of anticoagulation provides apparently little to no benefit and likely more harm. Reminds me of the rAPC situation for managing sepsis ☹️
RT @rbganatra: 1/ What is the risk of macrovascular thrombosis among critically ill patients with #SARSCoV2 #COVID19? Let’s take a look at…
RT @rbganatra: 1/ What is the risk of macrovascular thrombosis among critically ill patients with #SARSCoV2 #COVID19? Let’s take a look at…
RT @rbganatra: 1/ What is the risk of macrovascular thrombosis among critically ill patients with #SARSCoV2 #COVID19? Let’s take a look at…
RT @rbganatra: 1/ What is the risk of macrovascular thrombosis among critically ill patients with #SARSCoV2 #COVID19? Let’s take a look at…
A tour de force analysis done by @rbganatra on a recent COVID macrovascular thrombosis study. Amazingly succinct and insightful. Thank you Rahul!
Another great analysis of an important article on thrombotic complications in COVID-19 patients. Check it out! #COVID19 #thrombosis #CriticalThinking
Another enlightening appraisal by @rbganatra about an article on thrombotic complications in critically ill ICU patients with COVID-19.
Incidence of thrombotic complications in critically ill ICU patients w... https://t.co/pCjcfVxaNO
RT @rbganatra: 1/ What is the risk of macrovascular thrombosis among critically ill patients with #SARSCoV2 #COVID19? Let’s take a look at…
1/ What is the risk of macrovascular thrombosis among critically ill patients with #SARSCoV2 #COVID19? Let’s take a look at the data. Here’s #HowIReadThisPaper on a @ThromboisRese1 case series examining this question: Klok et al: https://t.co/Iug13PCSVw
Incidence of thrombotic complications in critically ill ICU patients with COVID-19 https://t.co/fokcJR6zDG